Paper39939124
Time trends of variability in disease activity in systemic lupus erythematosus.
Li N and 38 others. Lupus Sci Med, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Time trends of variability in disease activity in systemic lupus erythematosus. Papers, record 39939124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39939124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lupus Erythematosus, Systemic | Major topic |
| Humans | |
| Female | |
| Male | |
| Adult | |
| Severity of Illness Index | |
| Middle Aged | |
| Time Factors | |
| Young Adult |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20833737 | An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. | Ann Rheum Dis | 2011 | https://conductscience.org/library/papers/20833737 | PubMed |
| 2 | 32789462 | Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties. | Rheumatology (Oxford) | 2020 | https://conductscience.org/library/papers/32789462 | PubMed |
| 3 | 28243457 | Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort. | Lupus Sci Med | 2017 | https://conductscience.org/library/papers/28243457 | PubMed |
| 4 | 30398013 | Development of the Asia Pacific Lupus Collaboration cohort. | Int J Rheum Dis | 2019 | https://conductscience.org/library/papers/30398013 | PubMed |
| 5 | 38287623 | Clinician-reported outcome measures in lupus trials: a problem worth solving. | Lancet Rheumatol | 2021 | https://conductscience.org/library/papers/38287623 | PubMed |
| 6 | 22553077 | Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. | Arthritis Rheum | 2012 | https://conductscience.org/library/papers/22553077 | PubMed |
| 7 | 28470594 | How to Appropriately Extrapolate Costs and Utilities in Cost-Effectiveness Analysis. | Pharmacoeconomics | 2017 | https://conductscience.org/library/papers/28470594 | PubMed |
| 8 | 8607884 | The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. | Arthritis Rheum | 1996 | https://conductscience.org/library/papers/8607884 | PubMed |
| 9 | 9324032 | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. | Arthritis Rheum | 1997 | https://conductscience.org/library/papers/9324032 | PubMed |
| 10 | 12966601 | Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. | J Rheumatol | 2003 | https://conductscience.org/library/papers/12966601 | PubMed |
| 11 | 32723809 | Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations. | Lupus Sci Med | 2020 | https://conductscience.org/library/papers/32723809 | PubMed |
| 12 | 33280012 | Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. | Rheumatology (Oxford) | 2020 | https://conductscience.org/library/papers/33280012 | PubMed |
| 13 | 25234659 | An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort. | Rheumatology (Oxford) | 2015 | https://conductscience.org/library/papers/25234659 | PubMed |
| 14 | 11838846 | Systemic lupus erythematosus disease activity index 2000. | J Rheumatol | 2002 | https://conductscience.org/library/papers/11838846 | PubMed |
| 15 | 15868616 | Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE. | J Rheumatol | 2005 | https://conductscience.org/library/papers/15868616 | PubMed |
| 16 | 36655777 | SLE disease activity stabilizes over time: a hypothesis stimulated by a model reported a few years ago and recently re-tested. | Rheumatology (Oxford) | 2023 | https://conductscience.org/library/papers/36655777 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42377326 | Distinct Longitudinal Trajectories of SLEDAI-2K Scores Predict Prognosis in Systemic Lupus Erythematosus Based on Group-Based Trajectory Modeling. | J Immunol Res | 2026 | https://conductscience.org/library/papers/42377326 | PubMed |
| 41806136 | Clinical significance of miR-146a-5p and miR-192-5p expression in relation to disease activity and immunobiochemical markers in systemic lupus erythematosus. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41806136 | PubMed |
| 41146881 | Novel variants in ARID1B, SPSB1, and RAET1-AS shape genetic susceptibility and protection in systemic lupus erythematosus and lupus nephritis. | J Transl Autoimmun | 2025 | https://conductscience.org/library/papers/41146881 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39939124
GET https://conductscience.org/api/papers/v1/39939124/authors?page=2